Linkage studies for T2D in chop and C/EBPbeta chromosomal regions in Italians

Journal of Cellular Physiology

Volumn 213, Issue 2, 2007, Pages 552-555

  Gragnoli, Claudia ^a,b,c   Pierpaoli, Laura ^c   Piumelli, Nunzia ^c   Chiaramonte, Francesco ^d  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c Bios Biotech Multi Diagnostic Health Center   (Italy)

^d SPIRITO SANTO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153;

ADULT; ARTICLE; C EBPBETA GENE; CHOP GENE; CHROMOSOME 12Q; CHROMOSOME 20Q; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE LOCATION; GENETIC LINKAGE; GENOTYPE; HUMAN; INSULIN RESISTANCE; ITALY; MALE; MICROSATELLITE MARKER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ADULT; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CHROMOSOMES, HUMAN, PAIR 12; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; GENE FREQUENCY; GENOTYPE; HUMANS; ITALY; LINKAGE (GENETICS); TRANSCRIPTION FACTOR CHOP;

EID: 34848866902     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21132     Document Type: Article

References (53)

1. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. 2002. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 30:97-101.
2. Arizmendi C, Liu S, Croniger C, Poli V, Friedman JE. 1999. The transcription factor CCAAT/enhancer-binding protein beta regulates gluconeogenesis and phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes. J Biol Chem 274:13033-13040.
3. Baier LJ, Permana PA, Yang X, Pratley RE, Hanson RL, Shen GQ, Mott D, Knowler WC, Cox NJ, Horikawa Y, Oda N, Bell GI, Bogardus C. 2000. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest 106:R69-R73.
4. Batchvarova N, Wang XZ, Ron D. 1995. Inhibition of adipogenesis by the stress-induced protein CHOP (Gadd153). EMBO J 14:4654-4661.
5. Bektas A, Suprenant ME, Wogan LT, Plengvidhya N, Rich SS, Warram JH, Krolewski AS, Doria A. 1999. Evidence of a novel type 2 diabetes locus 50 cM centromeric to NIDDM2 on chromosome 12q. Diabetes 48:2246-2251.
6. Bektas A, Hughes JN, Warram JH, Krolewsky AS, Doria A. 2001. Type 2 diabetes locus on 12q15. Further mapping and mutation screening of two candidate genes. Diabetes 50:204-208.
7. Bowden DW, Sale M, Howard TD, Qadri A, Spray BJ, Rothschild CB, Akots G, Rich SS, Freedman BI. 1997. Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes 46:882-886.
8. Byrne MM, Sturis J, Menzel S, Yamagata K, Fajans SS, Dronsfield MJ, Bain SC, Hattersley AT, Velho G, Froguel P, Bell GI, Polonsky KS. 1996. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes 45:1503-1510.
9. Carlson SG, Fawcett TW, Bartlett JD, Bernier M, Holbrook NJ. 1993. Regulation of the C/EBP-related gene gadd153 by glucose deprivation. Mol Cell Biol 13:4736-4744.
10. Chen C, Dudenhausen EE, Pan YX, Zhong C, Kilberg MS. 2004. Human CCAAT/enhancer-binding protein beta gene expression is activated by endoplasmic reticulum stress through an unfolded protein response element downstream of the protein coding sequence. J Biol Chem 279:27948-27956.
11. Cortes-Canteli M, Pignatelli M, Santos A, Perez-Castillo A. 2002. CCAAT/enhancer-binding protein beta plays a regulatory role in differentiation and apoptosis of neuroblastoma cells. J Biol Chem 277:5460-5467.
12. Darville MI, Eizirik DL. 2001. Cytokine induction of Fas gene expression in insulin-producing cells requires the transcription factors NF-kappaB and C/EBP. Diabetes 50:1741-1748.
13. Ehm MG, Karnoub MC, Sakul H, Gottschalk K, Holt DC, Weber JL, Vaske D, Briley D, Briley L, Kopf J, McMillen P, Nguyen Q, Reisman M, Lai EH, Joslyn G, Shepherd NS, Bell C, Wagner MJ, Burns DK. 2000. Genomewide search for type 2 diabetes susceptibility genes in four American populations. Am J Hum Genet 66:1871-1881.
14. Fingerlin TE, Boehnke M, Abecasis GR. 2004. Increasing the power and efficiency of disease-marker case-control association studies through use of allele-sharing information. Am J Hum Genet 74:432-443.
15. Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, et al. 1993. Familial hyperglicemia due to mutations in glucokinase: Definition of a subtype of diabetes mellitus. New Engl J Med 328:697-702.
16. Ghosh S, Watanabe RM, Hauser ER, Valle T, Magnuson VL, Erdos MR, Langefeld CD, Balow J. Jr., Ally DS, Kohtamaki K, Chines P, Birznieks G, Kaleta HS, Musick A, Te C, Tannenbaum J, Eldridge W, Shapiro S, Martin C, Witt A, So A, Chang J, Shurtleff B, Porter R, Boehnke M, et al. 1999. Type 2 diabetes: Evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci USA 96:2198-2203.
17. Godart F, Bellanne-Chantelot C, Clauin S, Gragnoli C, Abderrahmani A, Blanche H, Boutin P, Chevre JC, Froguel P, Bailleul B. 2000. Identification of seven novel nucleotide variants in the hepatocyte nuclear factor-1alpha (TCFI) promoter region in MODY patients. Hum Mutat 15:173-180.
18. Gragnoli C. 2007. Kir6.2 (KCNJ11) E23K variant in type 2 diabetes in Italians. Obesity Metab (in press).
19. Gragnoli C, Lindner T, Cockburn BN, Kaisaki PJ, Gragnoli F, Marozzi G, Bell GI. 1997. Maturity-onset diabetes of the young due to a mutation in the hepatocyte nuclear factor-4 alpha binding site in the promoter of the hepatocyte nuclear factor-1 alpha gene. Diabetes 46:1648-1651.
20. Gragnoli C, Cockburn BN, Chiaramonte F, Gorini A, Marietti G, Marozzi G, Signorini AM. 2001. Early-onset Type II diabetes mellitus in Italian families due to mutations in the genes encoding hepatic nuclear factor 1 alpha and glucokinase. Diabetologia 44:1326-1329.
21. Gragnoli C, Milord E, Habener JF. 2005a. Linkage study of the glucagon receptor gene with type 2 diabetes mellitus in Italians. Metabolism 54:786-787.
22. Gragnoli C, Stanojevic V, Gorini A, Von Preussenthal GM, Thomas MK, Habener JF. 2005b. IPF-1/MODY4 gene missense mutation in an Italian family with type 2 and gestational diabetes. Metabolism 54:983-988.
23. Gragnoli C, Cronsell J. 2007a. Metanalysis of the IPF1 D76N polymorphism in a worldwide type 2 diabetes population. Minerva Medica (in press).
24. Gragnoli C, Cronsell J. 2007b. PPARgamma P12A variant in type 2 diabetes in Italians. Obesity Metab (in press).
25. Gragnoli C, Cronsell J. 2007c. PSMD9 gene variants within NIDDM2 may rarely contribute to type 2 diabetes. J Cell Physiol (in press).
26. Hanis CL, Boerwinkle E, Chakraborty R, Ellsworth DL, Concannon P, Stirling B, Morrison VA, Wapelhorst B, Spielman RS, Gogolin-Ewens KJ, Shepard JM, Williams SR, Risch N, Hinds D, Iwasaki N, Ogata M, Omori Y, Petzold C, Rietzch H, Schroder HE, Schulze J, Cox NJ, Menzel S, Boriraj VV, Chen X, et al. 1996. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2 [see comments]. Nat Genet 13:161-166.
27. Hattori T, Ohoka N, Inoue Y, Hayashi H, Onozaki K. 2003. C/EBP family transcription factors are degraded by the proteasome but stabilized by forming dimer. Oncogene 22:1273-1280.
28. Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn BN, Lindner T, Yamagata K, Ogata M, Tomonaga O, Kuroki H, Kasahara T, Iwamoto Y, Bell GI. 1997. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY [letter]. Nat Genet 17:384-385.
29. Ji L, Malecki M, Warram JH, Yang Y, Rich SS, Krolewski AS. 1997. New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes 46:876-881.
30. Jousse C, Bruhat A, Harding HP, Ferrara M, Ron D, Fafournoux P. 1999. Amino acid limitation regulates CHOP expression through a specific pathway independent of the unfolded protein response. FEBS Lett 448:211-216.
31. Kilberg MS, Barbosa-Tessmann IP. 2002. Genomic sequences necessary for transcriptional activation by amino acid deprivation of mammalian cells. J Nutr 132:1801-1804.
32. Kim JW, Ahn YH. 1998. CCAAT/enhancer binding protein regulates the promoter activity of the rat GLUT2 glucose transporter gene in liver cells. Biochem J 336:83-90.
33. Laszik A, Brinkmann B, Sotonyi P, Falus A. 2000. Automated fluorescent detection of a 10 loci multiplex for paternity testing. Acta Biol Hung 51:99-105.
34. Lin B, Morris DW, Chou JY. 1997. The role of HNF1alpha. HNF3gamma, and cyclic AMP in glucose-6-phosphatase gene activation. Biochemistry 36:14096-14106.
35. Lu M, Seufert J, Habener JF. 1997. Pancreatic beta-cell-specific repression of insulin gene transcription by CCAAT/enhancer-binding protein beta. Inhibitory interactions with basic helix-loop-helix transcription factor E47. J Biol Chem 272:28349-28359.
36. Malecki M, Jhala U, Antonellis A, Fields L, Doria A, Orban T, Saad M, Warram J, Montminy M, Krolewski A. 1999. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet 23:323-328.
37. Medici F, Hawa M, Ianari A, Pyke DA, Leslie RD. 1999. Concordance rate for type II diabetes mellitus in monozygotic twins: Actuarial analysis [see comments]. Diabetologia 42:146-150.
38. Milord E, Gragnoli C. 2006. NEUROG3 variants and type 2 diabetes in Italians. Minerva Med 97:373-378.
39. Milord E, Gragnoli C. 2007. Chromosome 10 locus in linkage to type 2 diabetes in Italians. Obes Metabolism 3:1-4.
40. Ron D, Habener JF. 1992. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev 6:439-453.
41. Saisanit S, Sun XH. 1997. Regulation of the pro-B-cell-specific enhancer of the Id1 gene involves the C/EBP family of proteins. Mol Cell Biol 17:844-850.
42. Seufert J, Weir GC, Habener JF. 1998. Differential expression of the insulin gene transcriptional repressor CCAAT/enhancer-binding protein beta and transactivator islet duodenum homeobox-1 in rat pancreatic beta cells during the development of diabetes mellitus. J Clin Invest 101:2528-2539.
43. Shen CN, Seckl JR, Slack JM, Tosh D. 2003. Glucocorticoids suppress beta-cell development and induce hepatic metaplasia in embryonic pancreas. Biochem J 375:41-50.
44. Stoffers DA, Ferrer J, Clarke WL, Habener JF. 1997. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1 [letter]. Nat Genet 17:138-139.
45. Van den Ouweland JMW, Lemkes HHPJ, Ruitenbeek W, Sandkuijl LA, de Vijlder MF, Struyvenberg PA, van de Kamp JJ, Maassen JA. 1992. Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabets mellitus and deafness. Nat Genet 1: 368-371.
46. Wang L, Shao J, Muhlenkamp P, Liu S, Klepcyk P, Ren J, Priedman JE. 2000. Increased insulin receptor substrate-1 and enhanced skeletal muscle insulin sensitivity in mice lacking CCAAT/enhancer-binding protein beta. J Biol Chem 275:14173-14181.
47. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell Gi. 1996a. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1) [see comments]. Nature 384:458-460.
48. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj W, Chen X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigori H, Takeda J, Fajans SS, Hattersley AT, Iwasaki N, Hansen T, Pedersen O, Polonsky KS, Bell GI, et al. 1996b. Mutations in the hepatocyte nuclear factor-1 alpha gene in maturity- onset diabetes of the young (MODY3) [see comments]. Nature 384:455-458.
49. Yamamoto H, Kurebayashi S, Hirose T, Kouhara H, Kasayama S. 2002. Reduced IRS-2 and GLUT4 expression in PPARgamma2-induced adipocytes derived from C/EBPbeta and C/EBPdelta-deficient mouse embryonic fibroblasts. J Cell Sci 115:3601-3607.
50. Zhao Q, Wang J, Levichkin IV, Stasinopoulos S, Ryan MT, Hoogenraad NJ. 2002. A mitochondrial specific stress response in mammalian cells. EMBO J 21:4411-4419.
51. Zhou YP, Sreenan S, Pan CY, Currie KP, Bindokas VP, Horikawa Y, Lee JP, Ostrega D, Ahmed N, Baldwin AC, Cox NJ, Fox AP, Miller RJ, Bell GI, Polonsky KS. 2003. A 48-hour exposure of pancreatic islets to calpain inhibitors impairs mitochondrial fuel metabolism and the exocytosis of insulin. Metabolism 52:528-534.
52. Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, Remotti H, Stevens JL, Ron D. 1998. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 12:982-995.
53. Zouali H, Hani EH, Philippi A, Vionnet N, Beckmann JS, Demenais F, Froguel P. 1997. A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. Hum Mol Genet 6:1401-1408.